LIVE #WCLC26 — live KOL coverage of the World Conference on Lung Cancer View Full Coverage →
KOL Pulse · KOL Digest

AI in Oncology

Oncologists in their own words on AI in clinical practice — knowledge tools, patient-facing AI, AI-derived biomarkers, and regulation. Every post verbatim and in full.

Latest edition · August 25, 2026
AI-read TILs, 'Peer-Unreviewed' in Annals, 66% physician adoption - and residents beating radiology AI

In this edition: Mali Barbi, MD asks whether AI-read TILs are the next PD-L1 · Ilana Schlam, MD shares AI TIL data from NSABP B-41 · Samer Al Hadidi, MD publishes 'Peer-Unreviewed' in Annals of Internal Medicine and Eric Topol, MD flags it · Karun Neupane, MD on omission errors in AI summaries · Sawyer Bawek, DO on Doximity's 66% physician AI adoption · Laura Heacock, MD on residents outperforming radiology AI · Allan Pereira, MD, PhD on the LiON prospective AI reader in Nature Medicine · Hidehito Horinouchi, MD and Fabio Moraes, MD preview AI at WCLC26 · Zeke Emanuel, MD on AI's improvement curve · Anish Koka, MD debates the Khosla thesis · Andrew Portuguese, MD builds with local AI · Arturo Loaiza-Bonilla, MD on Amara's law and the AI Oncology Revolution podcast · Shiv Rao, MD on Abridge's thesis · Yair Einhorn on AI's limits in biotech R&D · Bo Wang on the AI-designed individualized vaccine trial · VJHemOnc on an ML six-gene myeloma signature

18 voices · read the edition →
Edition · August 18, 2026
JAMA: the case for AI alone, vibe coding, and a hallucinated peer-reviewed pub

In this edition: JAMA's new Perspective argues AI alone may exceed physicians on cognitive medical tasks · co-authors Zeke Emanuel, MD and Vinod Khosla make the case · Eric Topol, MD flags the argument · Yakup Ergün, MD largely agrees — and says what physicians still own · physician-founder Joseph Younis, MD on the paper's conflicts of interest · Santhosh Ambika, MD on workforce oversupply · Jeff Ryckman, MD on Abridge saving an hour a day — and on an EviCore denial built on AI-hallucinated literature · Jean-Charles Soria, MD on AI in pharma R&D · The ASCO Post's AI week in review.

12 voices · read the edition →
Edition · August 12, 2026
AI is replacing the reference tools, and the journals are setting limits

In this edition: Aaron Goodman, MD on AI replacing UpToDate · David S. Hong, MD on building his own RAS dashboard · Noah Lindenberg, MD on the limits of OpenEvidence · Yüksel Ürün, MD on where JAMA draws the line between AI assistance and authorship · Hashem El-Serag, MD on JAMA's new manuscript guidance · The ASCO Post on a study in which physicians kept following incorrect AI classifications.

6 voices · read the edition →
Edition · August 10, 2026
AI is already in the clinic

In this edition: Aaron Goodman, MD on AI replacing UpToDate in daily use · Katy Beckermann, MD, PhD on AI tools in the community clinic · Estela Rodriguez, MD on patients bringing AI answers to the visit · Antonio Giordano, MD, PhD on AI-scored TROP2 · Andrew Pannu on AI in biopharma intelligence teams · Jame Abraham, MD on Cleveland Clinic's AI Summit, Aug 28.

6 voices · read the edition →
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • Enhanced KOL profiles
  • Pharma influence & potential advisory-board patterns
  • 2025 Open Payments financial analysis
  • Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.